UK Markets open in 7 hrs 14 mins

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
29.25+0.18 (+0.62%)
At close: 4:00PM EDT

29.30 +0.05 (0.17%)
After hours: 5:44PM EDT

Currency in USD

Valuation measures

Market cap (intra-day) 510.4B
Enterprise value 334.84B
Trailing P/E N/A
Forward P/E 15.99
PEG ratio (5-yr expected) 11.01
Price/sales (ttm)1.30
Price/book (mrq)19.44
Enterprise value/revenue 34.34
Enterprise value/EBITDA 711.03

Trading information

Stock price history

Beta (5Y monthly) 1.73
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 334.80
52-week low 314.78
50-day moving average 332.17
200-day moving average 323.38

Share statistics

Avg vol (3-month) 35.22M
Avg vol (10-day) 31.95M
Shares outstanding 5355.66M
Implied shares outstanding 6N/A
Float 275.79M
% held by insiders 12.94%
% held by institutions 169.35%
Shares short (14 Apr 2021) 415.75M
Short ratio (14 Apr 2021) 43.97
Short % of float (14 Apr 2021) 45.07%
Short % of shares outstanding (14 Apr 2021) 44.43%
Shares short (prior month 14 Mar 2021) 414.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 409 Nov 2010
Last split factor 22:1
Last split date 315 Oct 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin -6.98%
Operating margin (ttm)16.62%

Management effectiveness

Return on assets (ttm)2.56%
Return on equity (ttm)-64.22%

Income statement

Revenue (ttm)8.03B
Revenue per share (ttm)22.61
Quarterly revenue growth (yoy)-0.50%
Gross profit (ttm)5.78B
Net income avi to common (ttm)-560M
Diluted EPS (ttm)-1.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)605M
Total cash per share (mrq)1.7
Total debt (mrq)24.2B
Total debt/equity (mrq)4,000.66
Current ratio (mrq)1.09
Book value per share (mrq)1.50

Cash flow statement

Operating cash flow (ttm)1.11B
Levered free cash flow (ttm)446M